TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 118 filers reported holding TRICIDA INC in Q3 2020. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,343,000 | -67.8% | 368,944 | -2.4% | 0.00% | -75.0% |
| Q2 2020 | $10,388,000 | +35.2% | 378,006 | +8.2% | 0.00% | 0.0% |
| Q1 2020 | $7,685,000 | -35.4% | 349,327 | +10.9% | 0.00% | 0.0% |
| Q4 2019 | $11,892,000 | +22.3% | 315,103 | +0.0% | 0.00% | 0.0% |
| Q3 2019 | $9,724,000 | -22.1% | 315,007 | -0.4% | 0.00% | -20.0% |
| Q2 2019 | $12,476,000 | +20.8% | 316,172 | +18.2% | 0.01% | +25.0% |
| Q1 2019 | $10,330,000 | +113.3% | 267,486 | +30.2% | 0.00% | +100.0% |
| Q4 2018 | $4,844,000 | -21.2% | 205,409 | +2.1% | 0.00% | -33.3% |
| Q3 2018 | $6,146,000 | +2.2% | 201,170 | -0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,016,000 | – | 201,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |